| BCBS Texas Medical Policies | Chemical Peels | 2025-09-01 |
| BCBS Texas Medical Policies | Inhaled Nitric Oxide | 2025-09-01 |
| BCBS Texas Medical Policies | Mirikizumab-mrkz | 2025-09-01 |
| BCBS Texas Medical Policies | Nonpharmacologic Treatment of Rosacea | 2025-09-01 |
| BCBS Texas Medical Policies | Romosozumab-aqqg | 2025-09-01 |
| UHC Medicare Advantage | Ambulatory Electrocardiographic (AECG) Monitoring – Medicare Advantage Medical Policy | 2025-09-01 |
| UHC Medicare Advantage | Ear, Nose, and Throat Procedures – Medicare Advantage Medical Policy | 2025-09-01 |
| UHC Medicare Advantage | Skilled Nursing Facility, Rehabilitation, and Long-Term Acute Care Hospital – Medicare Advantage Medical Policy | 2025-09-01 |
| UHC UMR Medical and Drug | Reblozyl® (Luspatercept-Aamt) – Commercial Medical Benefit Drug Policy | 2025-09-01 |
| UHC UMR Medical and Drug | Susvimo® (Ranibizumab Injection) – Commercial Medical Benefit Drug Policy | 2025-09-01 |